Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $2.95 Million - $3.55 Million
13,235 New
13,235 $3.42 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $39.5 Million - $45.6 Million
-143,458 Reduced 53.24%
125,980 $35.9 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $16.1 Million - $18.3 Million
-62,627 Reduced 18.86%
269,438 $74.9 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $47.5 Million - $57.7 Million
188,033 Added 130.55%
332,065 $92 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $28 Million - $38.7 Million
144,032 New
144,032 $38.5 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $24.2 Million - $31.6 Million
-85,613 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $17.6 Million - $28.2 Million
67,888 Added 383.01%
85,613 $29.6 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $3.34 Million - $3.92 Million
13,766 Added 347.71%
17,725 $4.96 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $931,336 - $1.4 Million
3,942 Added 23188.24%
3,959 $969,000
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $1.02 Million - $1.18 Million
-3,850 Reduced 99.56%
17 $5,000
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $41.2 Million - $54.5 Million
-159,223 Reduced 97.63%
3,867 $1.04 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $6.52 Million - $8.27 Million
24,245 Added 17.46%
163,090 $51.6 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $30.6 Million - $42.2 Million
138,845 New
138,845 $41.2 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $9,132 - $10,242
-42 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $433,974 - $478,363
-1,979 Reduced 97.92%
42 $10,000
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $46.6 Million - $72.9 Million
-215,110 Reduced 99.07%
2,021 $478,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $22.4 Million - $28.4 Million
-80,405 Reduced 27.02%
217,131 $65.3 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $83.6 Million - $109 Million
284,735 Added 2224.32%
297,536 $105 Million
Q2 2018

Jul 19, 2018

SELL
$257.52 - $306.91 $417,182 - $497,194
-1,620 Reduced 11.23%
12,801 $3.72 Million
Q1 2018

May 10, 2018

BUY
$260.13 - $367.91 $284,061 - $401,757
1,092 Added 8.19%
14,421 $3.95 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $1.7 Million - $1.91 Million
5,537 Added 71.06%
13,329 $4.25 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $2.19 Million - $2.57 Million
7,792
7,792 $2.44 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.